ENVB Projected Dividend Yield
Enveric Biosciences Inc ( NASDAQ : ENVB )Enveric Biosciences is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Co.'s pipeline of product candidates and ongoing development programs include: EV104 (Cannabidiol and Celecoxib Conjugate), which is used as the targeted indication of Osteoarthritis; EVM-201, which is used as the targeted indication of anxiety; EVM-301, which is used as the targeted indications of mental health indication; Cannabinoid-Infused Topical Product, which is used as the targeted indication of oncology-related skincare conditions; and Cannabinoid and COX-2 inhibitor Conjugation. 20 YEAR PERFORMANCE RESULTS |
ENVB Dividend History Detail ENVB Dividend News ENVB Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |